These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bioequivalence and Therapeutic Equivalence of Generic and Brand Bupropion in Adults With Major Depression: A Randomized Clinical Trial. Kharasch ED; Neiner A; Kraus K; Blood J; Stevens A; Schweiger J; Miller JP; Lenze EJ Clin Pharmacol Ther; 2019 May; 105(5):1164-1174. PubMed ID: 30460996 [TBL] [Abstract][Full Text] [Related]
8. [Uneasiness about the safety of bupropion as an aid to smoking cessation unjustified]. Offerhaus L Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2054. PubMed ID: 11695106 [No Abstract] [Full Text] [Related]
9. Withdrawal of generic budeprion for nonbioequivalence. Woodcock J; Khan M; Yu LX N Engl J Med; 2012 Dec; 367(26):2463-5. PubMed ID: 23216549 [No Abstract] [Full Text] [Related]
19. When do differences in dissolution profiles predict clinical problems? Ngo SN J Clin Pharm Ther; 2007 Apr; 32(2):111-2. PubMed ID: 17381660 [No Abstract] [Full Text] [Related]
20. Psychosis induced by low-dose bupropion: sensitization of dopaminergic system by past cocaine abuse? Hahn M; Hajek T; Alda M; Gorman JM J Psychiatr Pract; 2007 Sep; 13(5):336-8. PubMed ID: 17890983 [No Abstract] [Full Text] [Related] [Next] [New Search]